The increasing prevalence of neurological disorders, particularly Alzheimer’s disease and dementia, is significantly driving the growth of the global memantine industry. Growing awareness regarding cognitive health, rising geriatric population, and increasing demand for effective neurodegenerative disease treatments are contributing to market expansion worldwide. Pharmaceutical companies...

The pharmaceutical sector continues to experience steady expansion due to increasing demand for neurological and cardiovascular treatments worldwide. Raubasine, known for its therapeutic applications in improving cerebral blood circulation and supporting neurological health, has gained growing attention across the healthcare industry. Rising incidences of neurological disorders, increasing...